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Abstract: Drug addiction results from the interplay between social and biological factors. Among these, genetic variables 
play a major role. The use of genetically related inbred rat strains that differ in their preference for drugs of abuse is one 
approach of great importance to explore genetic determinants. Lewis and Fischer 344 rats have been extensively studied 
and it has been shown that the Lewis strain is especially vulnerable to the addictive properties of several drugs when com-
pared with the Fischer 344 strain. Here, we have used microarrays to analyze gene expression profiles in the frontal cortex 
and nucleus accumbens of Lewis and Fischer 344 rats. Our results show that only a very limited group of genes were dif-
ferentially expressed in Lewis rats when compared with the Fischer 344 strain. The genes that were induced in the Lewis 
strain were related to oxygen transport, neurotransmitter processing and fatty acid metabolism. On the contrary genes that 
were repressed in Lewis rats were involved in physiological functions such as drug and proton transport, oligodendrocyte 
survival and lipid catabolism. 
These data might be useful for the identification of genes which could be potential markers of the vulnerability to the  
addictive properties of drugs of abuse. 
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INTRODUCTION 
  Drug addiction arises from the interplay between social 
and biological factors. Among the later, genetic variables are 
thought to play a major role [1, 2]. This fact has been cor-
roborated in animal studies, especially in those involving 
Lewis (LEW) and Fischer 344 (F344) rats. These two rat 
strains show differential responses to both drugs of abuse 
and stressors [3]. LEW rats are more sensitive to the rein-
forcing properties of cocaine, morphine or ethanol and they 
faster acquire the self-administration of these drugs [4-9]. 
  On the other hand, LEW and F344 rats differ in several 
neurochemical parameters which are related to reward proc-
esses. For instance, LEW animals have higher levels of tyro-
sine hydroxylase in the ventral tegmental area (VTA) but 
lower levels in the nucleus accumbens (NAcc) when com-
pared with F344 rats [10-14]. There are also differences in 
the levels of μ opioid receptors in several brain regions be-
tween both strains and these proteins are differentially modu-
lated after morphine self-administration and during the ex-
tinction of this behavior [8]. Moreover, it has been shown 
that there are higher levels of dopamine in the NAcc-Core of 
LEW rats after acute administration of several drugs of abuse 
[15]. 
  Another important difference between both strains is the 
reactivity of the hypothalamic-pituitary-adenal (HPA) axis 
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which displays a higher activity in the F344 strain when 
compared with the LEW strain [3, 16, 17]. 
  Notwithstanding all the data referenced above, the differ-
ential gene expression pattern in areas of the reward circuit 
of these two strains was unexplored. Therefore we designed 
the following experiment where we used Affymetrix cDNA 
microarrays to study gene expression in two key components 
of the reward system, the NAcc and frontal cortex (FC) [18] 
of the addiction-prone LEW strain and its histocompatible 
control the F344 strain. 
MATERIALS AND METHODS 
Animals 
  Male F344 (n=9) and LEW (n=9) rats weighing 300-320 
g at the beginning of the experiments were used. 
  All animals were maintained at a constant temperature 
(20±2º C) in a 12 hours light-dark cycle (lights on at 08:00 
hours), with free access to food and water (commercial diet 
for rodents A04/A03; Panlab, Barcelona, Spain). All animals 
were maintained and handled according to European Union 
Laboratory Animal Care Rules (86/609/EEC Directive). 
RNA Extraction 
  Two weeks after arrival in the vivarium, the rats were 
lightly anesthetized with isoflourane and decapitated. Brains 
were quickly removed and the FC and NAcc dissected out on 
ice. After weighed, the tissue was preserved in RNAlater 
solution (Qiagen, United Kingdom) at 4ºC overnight and 
then at -20ºC until RNA extraction. All the procedures   
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instruments and work surfaces were thoroughly cleaned   
with RNAase Zap (Ambion, Spain) to prevent RNAase   
activity. Total RNA extraction was performed with RNAeasy 
extraction kit with in-column DNAase digestion (Qiagen, 
United Kingdom), according to manufacturer’s instructions. 
RNA quantity was determined by 260 nm absorbance and 
integrity was determined with an Agilent Bioanalyzer 2100 
(all samples showing a RIN >8). 
Microarray Analysis 
  For microarray studies we made 3 pools of RNA per 
structure and strain, resulting on 12 different pools of RNA 
(3 for NAcc of LEW rats, 3 for frontal cortex of LEW rats, 3 
for NAcc of F344 rats and 3 for frontal cortex of F344 rats). 
For each strain, RNA from 9 rats was used. 
  Probe preparation, hybridization and analysis were car-
ried out in the genomics core facility of the “Universidad 
Complutense de Madrid”. Probes for the Affymetrix Gene 
1.0 ST were prepared and hybridized to the array using the 
“GeneChip Whole Transcript Sense Target Labeling Assay” 
(Affymetrix) according to the manufacturer’s suggestions. 
Briefly, for each sample of 200 ng of total RNA, cDNA was 
synthesized with random hexamers tagged with a T7 pro-
moter sequence. The double-stranded cDNA was used as a 
template for amplification with T7 RNA polymerase to cre-
ate antisense cRNA. Next, random hexamers were used to 
reverse transcribe the cRNA to produce single-stranded 
sense strand DNA. The DNA was fragmented and labeled 
with terminal deoxynucleotidyl transferase. The probes from 
each pool were hybridized to the Affymetrix Gene 1.0 ST 
array for 16 h at 45ºC. Subsequently, arrays were scanned 
and gene expression indexes were calculated with the RMA 
software [19]. 
  Expression ratios higher than 2 were considered to reflect 
induction of gene expression whereas ratios lower than 0.5 
were taken as indexes of inhibition of expression. Signifi-
cance was set to p<0.05. 
RESULTS 
  For the sake of clarity, we have organized the data   
according to induction/inhibition and anatomical localization 
criteria (induction/inhibition only in the NAcc, only in the 
FC or in both) (See Tables 1-6). 
  Only a limited number of the genes studied were signifi-
cantly different between strains. LEW rats showed higher 
expression in both the NAcc and FC in only 5 of the genes 
included in the array. These genes were related to different 
functions such as protein transport, lipid metabolism, nitro-
gen metabolism, hydrolase activity or organismal develop-
ment (Table 1).  
  The number of genes that were significantly induced in 
the FC and not in the NAcc was higher in the LEW strain 
compared with the F344 strain. Two of these genes were 
related to oxygen transport (LOC689064 and MGC72973) 
and another pair was related to ion transport (Atp5g2 and 
Slc17a6, the latter being also involved in neurotransmitter 
uptake). The rest of the genes induced in the FC were in-
volved in different biological processes such as ADP-
ribosylation (Adprhl1), regulation of cell cycle (RGD1310778) 
and signal transduction (Gpr103) to mention just a few ex-
amples (see Table 2 for further details). 
  As for the NAcc, only a few genes were induced in this 
structure in the LEW strain, without alteration in FC expres-
sion patterns. These genes were involved in sodium transport 
(Slc10a4), sphingolipid metabolism (Fa2h_pred-
icted//Wdr59), cytokinesis (Anln), organismal development 
(Hydin) and apoptosis (Perpr) (see Table 3). 
  With regard to inhibited expression, the genes that were 
repressed in both the NAcc and FC in LEW rats compared 
with F344 were more numerous than those which were in-
duced. Interestingly, two of these genes (Nqo2 and Akr1b10) 
were involved in oxidation-reduction processes while the rest 
of the inhibited genes had diverse functions, such as calcium 
binding (Pvalb), sphingolipid metabolism (Sgms2) or drug 
transport (Abcg2) among others (see Table 4). 
  Specific gene expression inhibition in the FC comprised 
more genes, with a broader range of functions. More specifi-
cally, three of the genes that were inhibited in the FC but not 
in the NAcc were related to neurotransmitter regulation 
(transport, secretion/exocytosis: Sv2c, Unc13c and Sytl5 
respectively) and two of them were involved in organismal 
development (Dlx5 and Cml2). The others were related to 
biological processes such as membrane organization (Ap1s2), 
regulation of DNA damage (Chd1l), regulation of oligoden-
drocyte prolongations (Ermn) and apoptosis (Alox15) among 
others (Table 5). 
  Lastly, the genes inhibited in the NAcc but not in the FC 
were less in number and related to several functions, for   
example neurotransmitter transport (Slc6a20), cell growth 
(Igfbp2 and Igfbp6), DNA replication (Rad1) or proton 
transport (ATP8). 
Table 1.  Genes that were Induced Both in the NAcc and FC in LEW Rats as Compared with F344 Rats 
Gene Symbol  Gene Description  mRNA Accession No.  Biological Process 
Pitpnm1   phosphatidylinositol transfer protein, membrane-associated 1   NM_001008369   protein transport 
Acsm3   acyl-CoA synthetase medium-chain family member 3   NM_033231   lipid metabolic process 
Nit2   nitrilase family, member 2   NM_001034126   nitrogen compound metabolic process 
RGD1309362   similar to interferon-inducible GTPase   BC098065   hydrolase activity, acting on acid anhydrides 
RGD1561619_predicted   similar to Camello-like 2 (predicted)   XM_001074225   multicellular organismal development Gene Expression in NAcc and FC of LEW and F344 Rats  Current Neuropharmacology, 2011, Vol. 9, No. 1    145 
DISCUSSION 
  In this work we have used cDNA microarrays analysis to 
study the differential gene expression profile in the NAcc 
and FC of the addiction-prone LEW strain and its histocom-
patible control the F344 strain. Although further real-time 
PCR studies must now validate these preliminary results, it 
seems that there are four set of genes differentially expressed 
in both inbred rat strains. 
1. Induced Genes 
1.1. Genes that were Induced in Both the NAcc and FC in 
LEW Rats as Compared with F344 Rats 
  To the best of our knowledge, neither of the genes that 
were induced in LEW rats as compared with F344 rats in 
both the NAcc and FC had any known relationship to drug 
Table 2.  Genes that were Induced in the FC but not in the NAcc of LEW Rats as Compared with F344 Rats 
Gene Symbol  Gene Description  mRNA Accession No.  Biological Process 
Atp5g2   ATP synthase, H+ transporting, mitochondrial 
F0 complex, subunit C2 (subunit 9)  
NM_133556   ion transport (proton transport) 
LOC689064   beta-globin   NM_001111269   oxygen transport 
MGC72973   beta-glo   NM_198776   oxygen transport 
RGD1563482   similar to hypothetical protein FLJ38663   BC168187   unknown 
RGD1310778   similar to Putative protein C21orf45   BC167102   cell cycle 
LOC363306   hypothetical protein LOC363306   ENSRNOT00000041659   unknown 
Slc17a6   solute carrier family 17 (sodium-dependent 
inorganic phosphate cotransporter), member 6  
NM_053427   Ion transport /neurotransmitter uptake) 
Ccdc95   coiled-coil domain containing 95   NM_001013900   unknown 
Ccdc77   coiled-coil domain containing 77   ENSRNOT00000056200   unknown 
Adprhl1   ADP-ribosylhydrolase like 1   NM_001013054   protein amino acid de-ADP-ribosylation/ 
protein amino acid de-ADP-ribosylation 
RGD1307225   similar to MEGF6   NM_001107663   unknown 
Gpr103   G protein-coupled receptor 103   NM_198199   signal transduction/G-protein coupled receptor protein 
signaling pathway 
LOC692042   hypothetical protein LOC692042   XM_001081377   unknown 
LOC300308   similar to hypothetical protein 4930509O22   BC090074   protein amino acid phosphorylation 
LOC688778   similar to fatty aldehyde dehydrogenase-like   ENSRNOT00000024034   oxidation reduction/cellular aldehyde metabolic process 
 
Table 3.  Genes that were Induced only in the NAcc but not in the FC of LEW Rats as Compared with F344 Rats 
Gene Symbol  Gene Description  mRNA Accession No.  Biological Process 
Slc10a4   solute carrier family 10 (sodium/bile acid cotransporter family), member 4  NM_001008555   ion transport(sodium) 
Fa2h_predicted // 
Wdr59  
fatty acid 2-hydroxylase (predicted) // WD repeat domain 59   ENSRNOT00000025625   fatty acid biosynthetic process 
(sphingolipid metabolism) 
Tmem63a // Tmem6   transmembrane protein 63a // transmembrane protein 6   ENSRNOT00000004519   unknown 
Anln   anillin, actin binding protein (scraps homolog, Drosophila)   ENSRNOT00000024361   cytokinesis 
Hydin   hydrocephalus inducing   XM_226468   multicellular organismal  
development 
LOC365476   similar to chromosome 10 open reading frame 79   XM_345041   unknown 
RGD1559942   similar to hypothetical protein   ENSRNOT00000044984   Unknown 
Perp   PERP, TP53 apoptosis effector   NM_001106265   induction of apoptosis 146    Current Neuropharmacology, 2011, Vol. 9, No. 1  Higuera-Matas et al. 
Table 4.  Genes that were Inhibited both in the NAcc and FC of LEW Rats as Compared with F344 Rats 
Gene Symbol  Gene Description  mRNA Accession No.  Biological Process 
Myo5c   myosin VC   NM_001108167   secretory granule trafficking 
Pvalb   parvalbumin   NM_022499   calcium ion binding 
LOC679726   similar to spermatogenesis associated glutamate (E)-rich protein 4d  ENSRNOT00000040473   unknown 
Fcrls   Fc receptor-like S, scavenger receptor   NM_001107702   scavenger receptor activity 
Thoc4   THO complex 4   NM_001109602   nuclear mRNA splicing, via spliceosome 
Sucnr1   succinate receptor 1   NM_001001518   signal transduction (G-protein coupled 
receptor signaling) 
LOC686123   similar to leucine rich repeat and coiled-coil domain containing 1   ENSRNOT00000059442   protein binding 
Sgms2   sphingomyelin synthase 2   NM_001014043   fatty acid biosynthetic process  
(sphingolipid metabolism) 
Abcg2   ATP-binding cassette, sub-family G (WHITE), member 2   NM_181381   drug transport 
Nqo2   NAD(P)H dehydrogenase, quinone 2   NM_001004214   memory formation/ oxidation reduction 
Akr1b10   aldo-keto reductase family 1, member B10 (aldose reductase)   NM_001013084   oxidation reduction 
Ccdc42   coiled-coil domain containing 42   NM_001107009   unknown 
 
Table 5.  Genes that were Inhibited in the FC but not in the NAcc of LEW Rats as Compared with F344 Rats 
Gene Symbol  Gene Description  mRNA Accession No.  Biological Process 
Nxph4   neurexophilin 4   NM_021680   neuropeptide-like activity 
Slc35d3   solute carrier family 35, member D3   NM_001107522   unknown 
Sv2c   synaptic vesicle glycoprotein 2c   NM_031593   neurotransmitter transport 
Unc13c   unc-13 homolog C (C. elegans)   NM_173146   regulation of neurotransmitter secretion 
Lrrc1   leucine rich repeat containing 1   NM_001014268   protein binding 
Sytl5   synaptotagmin-like 5   NM_178333   exocytosis 
Dlx5   distal-less homeobox 5   NM_012943   multicellular organismal development/ 
nervous system development 
Lpl   lipoprotein lipase   NM_012598   lipid catabolic process/fatty acid biosynthetic process 
Ap1s2   adaptor-related protein complex 1, sigma 2 subunit   NM_001127531   intracellular protein transport/membrane organization 
Mme   membrane metallo endopeptidase   NM_012608   proteolysis 
Ermn   ermin, ERM-like protein   NM_001008311   regulation of cell projection organization(oligodendrocites) 
Dpyd   dihydropyrimidine dehydrogenase   NM_031027   oxidation reduction/ purine and pyrimidine  
base catabolic processes 
Cml2   Camello-like 2   NM_021668   multicellular organismal development 
Chd1l   chromodomain helicase DNA binding protein 1-like   NM_001107704   chromatin remodeling/response to DNA damage stimulus 
RGD1565493   similar to DKFZP434I092 protein   XR_007761   Unknown 
Alox15   arachidonate 15-lipoxygenase   NM_031010   anti-apoptosis/arachidonic acid metabolic process 
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Table 6.  Genes that were Inhibited in the NAcc of LEW rats as Compared with F344 Rats 
Gene Symbol  Gene Description  mRNA Accession No.  Biological Process 
Ifi27l   interferon, alpha-inducible protein 27-like   NM_203410   implantation 
ATP8   ATP synthase F0 subunit 8   ENSRNOT00000046201   ion transport (proton transport) 
Igfbp6   insulin-like growth factor binding protein 6   NM_013104   regulation of cell growth 
Rad1   RAD1 homolog (S. pombe)   NM_001106419   DNA replication 
Dkk3   dickkopf homolog 3 (Xenopus laevis)   NM_138519   multicellular organismal development/negative 
regulator of Wnt signaling pathway 
Igfbp2   insulin-like growth factor binding protein 2   NM_013122   regulation of cell growth 
Thrsp   thyroid hormone responsive   NM_012703   Protein binding (thyroid hormone-induced  
neuronal cell death) 
LOC684785   similar to pleckstrin homology domain-containing, family A 
(phosphoinositide binding specific) member 2  
ENSRNOT00000022097   Unknown 
Slc6a20   solute carrier family 6 (neurotransmitter transporter), member 20  NM_133296   neurotransmitter transport 
Ogn   osteoglycin   NM_001106103   protein binding 
 
addiction and were mainly involved in general homeostatic 
processes. 
1.2. Genes that were Induced in the FC but not in the NAcc 
as Compared with F344 Rats 
  Within the genes that were induced in the FC but not in 
the NAcc of LEW rats compared with F344 animals, Atp5g2 
could be related to drug addiction phenomena since it has 
been shown to be up-regulated in the pancreatic cells of al-
cohol-consuming rats, a fact which parallels with mitochon-
drial damage [20]. In nerve tissue, the up-regulated expres-
sion of this gene in the FC of LEW rats could also correlate 
with an enhanced sensitivity to alcohol-induced damage in 
LEW rats, a possibility which has not been explored as yet. 
The beta-globin gene (LOC 689064ç9 was also induced in 
the FC and not in the NAcc. An interaction between ethanol 
and beta-globin has been reported [21] since it has been 
shown that acetaldehyde, the major metabolite of ethanol 
forms adducts with the beta-globin chain of hemoglobin, 
which are typically used as a marker of ethanol consumption 
[21]. Although the functional implications of the increased 
expression of the beta-globin gene are not clear, it could be 
related to the stronger sensitivity to ethanol effects observed 
in the LEW strain [9]. Slc17a6 gene (which codes a vesicular 
glutamate transporter protein) was also induced in the FC of 
LEW rats when compared with F344 rats. Interestingly, this 
gene was found to be up-regulated in the VTA by extended 
alcohol and/or tobacco abuse in humans [22], suggesting a 
role for this gene in the enhanced sensitivity to alcohol re-
ported in the LEW strain. 
  ADP-ribosylation is a major mechanism for G-protein 
inactivation. In fact, G proteins have been shown to be   
altered in opiate-dependent patients [23] and Gi protein   
inactivation by pertussis-toxin-induced ADP-ribosylation is 
able to reverse some of the behavioral responses elicited by 
dopaminergic agents during cocaine withdrawal [24]. As 
regards this, the increased expression of the Adprhl1 gene 
(which de-ADP ribosylates G proteins) in the FC of LEW 
rats could be a compensatory mechanism for an increased 
ADP-ribosylation activity. This enhanced ADP-ribsylation 
could be related to altered withdrawal syndromes in these 
two strains. 
  The rest of the genes induced in the FC but not in the 
NAcc have either unknown functions or no clear relationship 
with drug addiction processes. 
1.3. Genes that were Induced in the NAcc but not in the FC 
of LEW Rats as Compared with F344 Rats 
  The next set of genes comprises those induced in the 
NAcc but not in the FC. Among these, one gene that merits 
mention here is the apoptosis-related gene Perp which is 
induced in degenerating dopamine neurons [25]. Given that 
dopaminergic toxicity has been sometimes associated to en-
hanced sensitivity to rewarding effects of several drugs [26, 
27], it is tempting to speculate that Perp enhanced expression 
in the NAcc of LEW rats could be related to higher toxicity 
following a dopaminergic insult resulting in augmented sen-
sitivity to the rewarding properties of drugs such as metham-
phetamine or ethanol. Nonetheless, this hypothesis has not 
been experimentally tested yet. The rest of the genes in this 
set have no clear relationship with drug addiction or reward. 
2. Repressed Genes 
2.1. Genes that were Repressed in the NAcc and FC in 
LEW Rats as Compared with F344 Rats 
  Among the genes that were inhibited in both the FC and 
NAcc of LEW rats compared with F344 animals, Pvalb is of 
special interest given that it is a marker for GABAergic neu-
rons and there are several reports in the literature showing 
that drugs of abuse alter the number of parvalbumin-
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[28, 29]. Another interesting gene which was inhibited in 
both structures was Sgms2, which codes sphingomyelin syn-
thase 2. Deficiency of this enzyme has been related to at-
tenuated NFB activation [30] which is a transcription factor 
involved in different aspects of drug addiction [31, 32]. An-
other gene which was inhibited was Nqo2 which is involved 
in oxidation-reduction reactions and has been associated with 
increased risk of methamphetamine-induced psychosis [33]. 
Interestingly, this gene is also implicated in plasticity 
mechanisms regulating learning and memory [34], processes 
that are also playing a central role in addictive behaviors [35, 
36]. The other genes in this set have no clear relationship 
with drug addiction or reward processes. 
2.2. Genes that were Repressed in the FC but not in the FC 
of LEW Rats as Compared with F344 Rats 
  We then examined the genes that were inhibited in the 
FC but not NAcc of LEW rats as compared with F344 rats. 
In this set of genes, Sv2c, the gene coding for synaptic vesi-
cle glycoprotein 2c was repressed. This protein binds to syn-
aptotagmin and regulates exocytosis [37], a process that is 
involved in normal synaptic transmission and in drug addic-
tion [38]. This is in accordance with the fact that Sytl5, the 
gene that codes the synaptotagmin-like 5 and which is also 
involved in neurotransmitter secretion, is down-regulated. 
Interestingly, the Unc13c gene was inhibited in the FC of 
LEW and this gene is also known for regulating neurotrans-
mitter secretion (Table 5). Therefore, three neurotransmitter 
release-related genes seem to be affected in the LEW strain. 
The relevance of this fact to normal synaptic function and 
addiction phenomena remains to be determined. The expres-
sion of Mme gene, which codes for the membrane metallo 
endopeptidase (enkephalinase) enzyme, was repressed in the 
FC but not the NAcc of LEW rats. This enzyme is responsi-
ble for the degradation of several endogenous peptides in-
cluding the enkephalins [39]. A lower expression of this en-
zyme would result in high enkephalin levels which are ob-
served after ethanol [40] or morphine [41] injections. Addi-
tionally, high levels of met-enkephalins are also responsible 
for attenuated withdrawal responses during opiate with-
drawal [42]. Chd1l gene was also repressed in the FC of 
LEW rats. The protein coded by this gene (chromodomain 
helicase DNA binding protein 1-like) is able to interact with 
Nur77 and inhibit its translocation from the nucleus to the 
mitochondria [43]. Nur77 is an apoptosis-related protein 
involved in amphetamine-induced locomotion [44] and co-
caine self-administration [45]. Interestingly, chronic cocaine 
upregulated the levels of NGFI-B/Nur77 family of nuclear 
orphan receptors in F344 rats while no effect was observed 
in LEW rats [46], highlighting differences in the dynamics of 
the expression of this gene in both strains in basal conditions 
as well as after drug challenges. Therefore, high levels of 
Nur77 (resulting from reduced Chd1l activity) could contrib-
ute to explain the enhanced susceptibility to drug self-
administration of the LEW strain. The rest of the genes of 
this set have no clear relationship to reward or drug addiction 
processes. 
2.3. Genes that were Repressed in the NAcc but not in the 
FC of LEW Rats as Compared with F344 Rat 
  Lastly, we found a reduced set of genes that were inhib-
ited in the NAcc but not FC of LEW rats as compared with 
F344 rats. ATP8 (coding subunit 8 of the ATP synthase en-
zyme) inhibition could have some importance in explaining 
the vulnerability to the addictive properties of drugs of 
abuse. In this sense, it has been already found that the alpha-
subunit of ATP synthase is differentially modulated in two 
subsets of rats which differed in the extinction of cocaine-
induced conditioned place preference [47]. Another couple 
of interesting genes was Igfbp6 and Igfbp2 which have been 
shown to be involved in mood disorders [48-50] and there-
fore could also have relevance to drug addiction given the 
interrelationship between both psychopathological spectra 
[51, 52]. The rest of the genes in this set have no direct or 
clear relationship to drug addiction. 
  In conclusion, we have found four set of genes (each one 
only including a limited number of examples) that may be 
useful markers of vulnerability to addiction. Further stud-
ies should validate these results and test the implication of 
each of the genes reported here in addiction-related phenom-
ena. 
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